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Background: Left ventricular (LV) function depends on the activity of transmembrane electrolyte transporters.
Failing human myocardium has lower Na+/K+ ATPase expression and higher intracellular sodium concentrations.
The ATP12A gene encodes a catalytic subunit of an ATPase that can function as a Na+/K+ pump. We, therefore,
investigated the association between LV function and common genetic variants in ATP12A.
Methods: A random sample of 1166 participants (53.7% women; mean age 49.5 years, 44.8% hypertensive) was
recruited in Belgium, Poland, Italy and Russia. We measured transmitral early and late diastolic velocities (E and A) by
pulsed wave Doppler, and mitral annular velocities (e’ and a’) by tissue Doppler. Using principal component analysis,
we summarized 7 Doppler indexes – namely, E, A, e’ and a’ velocities, and their ratios (E/A, e’/a’, and E/e’) – into a single
diastolic score. We genotyped 5 tag SNPs (rs963984, rs9553395, rs10507337, rs12872010, rs2071490) in ATP12A. In our
analysis we focused on rs10507337 because it is located within a transcription factor binding site.
Results: In the population-based analyses while adjusting for covariables and accounting for family clusters and
country, rs10507337 C allele carriers had significantly higher E/A (P = 0.003), e’ (P = 5.8×10−5), e’/a’ (P = 0.003) and
diastolic score (P = 0.0001) compared to TT homozygotes. Our findings were confirmed in the haplotype analysis
and in the family-based analyses in 74 informative offspring.
Conclusions: LV diastolic function as assessed by conventional and tissue Doppler indexes including a composite
diastolic score was associated with genetic variation in ATP12A. Further experimental studies are necessary to
clarify the role of ATP12A in myocardial relaxation.
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Left ventricular (LV) diastolic dysfunction refers to a con-
dition in which abnormalities in LV function are present
during diastole and is characterized by impaired relaxation
and/or filling of the heart. LV diastolic dysfunction is asso-
ciated with common risk factors such as hypertension and
it can progress to symptomatic heart failure [1]. The
prevalence of subclinical diastolic dysfunction in the* Correspondence: tatiana.kouznetsova@med.kuleuven.be
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unless otherwise stated.general population increases with age and is as high as
25.1% [2-5]. Echocardiographic measurement of diastolic
Doppler velocities of the transmitral blood flow (E and A
peaks) and the mitral annular movement (e’ and a’ peaks)
during early and late diastole allows the non-invasive
assessment of LV diastolic function [6]. Moreover, low e’
velocity measured by Tissue Doppler Imaging (TDI)
significantly and independently from other cardiovascular
risk factors predicted higher risk of fatal and nonfatal
cardiovascular events in patients with hypertension [7] or
heart failure [8] and in general population [9]. Recently we
demonstrated significant heritability of the diastolic Dop-
pler indexes [10]. Understanding to what extent geneticd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tors and lifestyle influence diastolic Doppler indexes is
an important issue in view of the relation of LV dia-
stolic dysfunction with outcome.
Cardiomyocyte contraction and relaxation depend on
the balance of electrolytes (calcium, sodium, potassium,
etc.) across the cellular membranes [11,12]. The electro-
lyte gradients are maintained by transmembrane channels
and adenosine triphosphate (ATP) dependent pumps. Ex-
perimental [13] and clinical studies [14] demonstrated that
intracellular sodium concentration (Na+) is increased in
failing cardiomyoctes as compared to normal myocar-
dium. The possible cause for this observation might be
related to changes in Na+/K+ ATPase expression and/or
function [11,12]. Among the genes that encode the cata-
lytic alpha subunit of Na+/K+-ATPase [15,16], ATP12A
belongs to the family of P-type cation transport ATPases
that can function as Na+/K+ ATPase in human cells [17].
Taking together, genetic variability in ATP12A might influ-
ence myocardial Na+ handling and consequently myocar-
dial function. We recently genotyped top SNPs that might
be associated with cardiovascular phenotypes and that
have been identified in a recent genome-wide association
study [18]. Among these SNPs common genetic variants
in ATP12A were genotyped. Therefore, in the Flemish
Study on Environment, Genes and Health Outcomes
(FLEMENGHO) and the European Project On Genes in
Hypertension (EPOGH) we investigated whether echocar-
diographic variables reflecting LV diastolic function are as-
sociated with common genetic variants in ATP12A.
Methods
Study participants
From August 1985 until December 2005, we randomly
recruited a family-based population sample (the FLE-
MENGHO cohort) from a geographically defined area in
northern Belgium as described in previous publications
[4]. EPOGH recruited nuclear families from 1999 until
2001. The EPOGH investigators were trained at the
Studies Coordinating Centre in Leuven, Belgium, and
applied the same protocol, questionnaires and proce-
dures, as used in FLEMENGHO [3]. All study partici-
pants provided a signed informed consent and the study
was approved by the Ethical Committees of the Univer-
sity of Leuven, the University of Padova, Jagiellonian
University Medical College, and the Novosibirsk Insti-
tute of Internal and Preventive Medicine. All clinical in-
vestigations were conducted according to the principles
expressed in the Declaration of Helsinki. The initial re-
sponse rate at enrolment was 75.0%.
In the FLEMENGHO study, from May 2005 until January
2010, we invited 1055 former participants from a previously
identified random population for a follow-up examination
at the field centre, including echocardiography. Of those,828 renewed their written consent. In the EPOGH study,
from January 2007 until September 2009, we invited 631
former participants for an examination including echocar-
diography. Of those, 561 gave their consent in writing.
We excluded 223 subjects from analysis, because DNA
was missing or of bad quality (n = 217), atrial fibrillation
(n = 1) or because LV diastolic Doppler indexes could
not be reliably measured (n = 5). Thus, 1166 subjects
were analyzed including 777 FLEMENGHO participants
(Noorderkempen, Belgium) and 389 EPOGH participants
from Krakow, Poland (n = 143), Mirano, Italy (n = 109) and
Novosibirsk, Russia (n = 137).
Echocardiography
The participants refrained from smoking, heavy exercise,
and drinking alcohol or caffeine-containing beverages
for at least 3 hours before echocardiography.
Data acquisition
In each center one experienced physician did the ultra-
sound examination, using a Vivid7 Pro (GE Vingmed,
Horten, Norway) interfaced with a 2.5- 3.5 MHz phased-
array probe, according to a standardized protocol as
published elsewhere [3,4]. With the subjects in partial
left decubitus and breathing normally, the observer ob-
tained images, together with a simultaneous ECG signal,
from the parasternal long and short axes and from the
apical 4- and 2-chamber long-axis views. M-mode echo-
cardiograms of the LV were recorded from the paraster-
nal long-axis view under control of the 2D image. The
ultrasound beam was positioned just below the mitral
valve at the level of the posterior chordae tendineae. To
record mitral flow velocities from the apical window, we
positioned the Doppler sample volume at the mitral
valve tips.
Using TDI, the observer recorded low-velocity, high-
intensity myocardial velocity at a high frame rate (>190
FPS), while adjusting the imaging angle to ensure paral-
lel alignment of the ultrasound beam with the myocar-
dial segment of interest. From the apical window, a
5 mm Doppler sample was placed at the septal, lateral,
inferior and posterior sites of the mitral annulus to ob-
tain the pulsed wave TDI velocities.
Off-line analysis
All echocardiographic recordings included at least 5 car-
diac cycles and were digitally stored for off-line analysis.
One experienced observer (TK) analyzed the digitally
stored images from all centers, using the EchoPac soft-
ware, version 4.0.4 (GE Vingmed, Horten, Norway),
selecting and averaging 3 cardiac cycles obtained at the
end-expiration. The observer was blinded to the genetic
results. LV internal diameter and interventricular septal
and posterior wall thickness were measured at end-
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cing according to the guidelines. When optimal orienta-
tion of M-mode ultrasound beam could not be obtained
(in approximately 5% of echocardiographic recordings),
the reader performed linear measurements on correctly
oriented two-dimensional images. End-diastolic left ven-
tricular dimensions were used to calculate LV mass by
an anatomically validated formula. LV mass was indexed
to body surface area (BSA). LV end-systolic and end-
diastolic volumes were measured off-line using the
standard biplane Simpson’s method.
We assessed LV diastolic function using recordings of
conventional blood flow and tissue Doppler velocities.
Pulsed-wave Doppler signals of transmitral blood flow
were used to measure peak early (E) and late (A) dia-
stolic velocities. From the pulsed wave TDI recordings,
we measured the early (e’) and late (a’) peak diastolic
velocities of the mitral annulus displacement, and the e’/
a’ ratio at the 4 acquisition sites. We calculated the E/e’
ratio by dividing transmitral E peak by e’ averaged from
the 4 acquisition sites. As reported previously [3], the
inter-observer intra-session reproducibility across the
four sampling sites ranged from 4.48% to 5.34% for e’
velocities and from 3.96% to 4.52% for a’ velocities.
Other measurements
We administered a standardized questionnaire to collect
detailed information on subjects’ medical history, smok-
ing and drinking habits, and intake of medications. The
conventional blood pressure was the average of five con-
secutive auscultatory readings obtained with the subject
in the seated position. Hypertension was defined as a blood
pressure of at least 140 mm Hg systolic or 90 mm Hg
diastolic or as use of antihypertensive drugs. Body mass
index was weight in kilograms divided by the square of
height in meters.
Genotypes
We extracted DNA from white blood cells. For genotyp-
ing of ATP12A SNPs we used 15 K Illumina Infinium
custom chip (Illumina Inc, San Diego, CA), designed for
the HYPERGENES project [18] to cover genes deemed
to be relevant for hypertension and related target organ
damage. Detailed information on the procedure of tag SNP
selection for the custom chip is provided in Additional
file 1. The human ATP12A gene lies within chromosome
13q12.1-q12.3 (http://www.ncbi.nlm.nih.gov/gene/479) and
spans approximately 32 kb. It contains 23 exons and 22
introns [19]. The selected 8 tag SNPs were annotated ac-
cording to the Genome Reference Consortium Human
Build 37 hg19 (Additional file 1: Table S1). Three SNPs
were excluded from the statistical analysis because of minor
allele frequency (MAF) = 0.02 (rs2289909), genotyping call-
rate <99% (rs1867767) or bad cluster according to IlluminaGenome Studio (rs1001806, Additional file 1: Table S1). Of
remaining 5 SNPs, rs963984, rs12872010 and rs2071490 lie
within coding regions, but do not alter the amino acid
sequence of the coded protein (synonymous). Two other
SNPs (rs9553395 and rs10507337) are located in the 5′
flanking region, with rs10507337 within a transcription fac-
tor binding site.
Statistical methods
For database management and statistical analysis, we
used SAS software, version 9.3 (SAS Institute, Cary,
NC). We compared means and proportions by the z
test and by the χ2 test, respectively. We tested mini-
mum allele frequency, proportion of missing genotypes
and Hardy-Weinberg equilibrium using JMP Genomics,
version 6.1 (SAS Institute, Cary, NC). We reconstructed
haplotypes using the PROC HAPLOTYPE procedure im-
plemented in the genetics module of the SAS software.
Principal component analysis
The diastolic Doppler velocities are measured using simi-
lar technique (Doppler) and are highly intra-correlated.
Therefore, some redundancy in the cumulative variance of
the Doppler velocities exists. This redundancy can be de-
creased by a mathematical procedure, the principal com-
ponent analysis. This thechnique enables summarization
of intra-correlated variables into an artificial score that
carries information from all the contributing variables. In-
dividual values of the artificial score are calculated by
summarization of optimally weighted values of the con-
tributing measured indexes. We, therefore, summarized
transmitral E and A blood flow velocities, averaged TDI e’
and a’ mitral annulus velocities and their ratios (E/A, e’/a’,
E/e’) into a single composite diastolic score. Normality of
diastolic score distribution was evaluated by Shapiro-
Wilk’s statistic and skewness by computation of the coeffi-
cient of skewness. The association between the composite
diastolic score and velocities was described using factors
loadings. We performed stepwise linear regression to iden-
tify correlates of the composite diastolic score with sex,
age, height, weight, body mass index, heart rate, systolic
and diastolic blood pressures, left ventricular mass index,
and ejection fraction. We set the P value for variables to
enter and stay in the regression models at 0.10.
Population-based analysis
First, we performed the association analyses of dependent
variables (LV phenotypes) with the genotypes or haplotypes
of interest by use of a mixed model in each examination
center. Covariables with known relevance for LV structure
and function [3] were included in the models as fixed ef-
fects, while family clusters was modeled as a random effect.
Then we performed the association analyses in all centers
combined while examination centers were modeled as
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homogeneous across examination centers. The heterogen-
eity test statistic (Cochran’s Q) was computed by summing
the squared deviations of each center estimate from the
overall meta-analytic estimate, weighting each center con-
tribution in the same manner as in the meta-analysis. We
also reported the P-values corrected for multiple testing
using the Bonferroni method.
Family-based analysis
We performed the transmission disequilibrium test for
quantitative traits (QTDT). We evaluated the within- and
between-family components of phenotypic variance using
the orthogonal model as implemented by Abecasis et al.Table 1 Characteristics of participants by country
Belgium
Characteristic (n = 777)
Anthropometrics
Female sex, n (%) 399 (51.4)
Age (years) 51.0 ± 15.5
Height (cm) 168.7 ± 9.4
Weight (kg) 75.5 ± 14.4
Body mass index (kg/m2) 26.5 ± 4.3
Systolic pressure (mmHg) 129.3 ± 17.6
Diastolic pressure (mmHg) 79.6 ± 9.4
Heart rate (beats/minute) 61.0 ± 9.7
Questionnaire data
Current smoking, n (%) 161 (20.7)
Drinking alcohol, n (%) 309 (39.8)
Hypertensive, n (%) 323 (41.6)
Treated for hypertension, n (%) 197 (25.4)
Conventional echocardiography
LV internal diameter (cm) 5.04 ± 0.47
Interventricular septum (cm) 0.98 ± 0.17
Posterior wall (cm) 0.90 ± 0.14
LV mass index (g/m2) 92.4 ± 22.0
Ejection fraction (%) 63.3 ± 6.75
Diastolic function
Transmitral E peak (cm/s) 75.5 ± 16.1
Transmitral A peak (cm/s) 65.0 ± 17.4
Transmitral E/A ratio 1.26 ± 0.48
TDI e’ peak (cm/s) 11.4 ± 3.65
TDI a’ peak (cm/s) 10.1 ± 2.11
e’/a’ ratio 1.26 ± 0.71
E/e’ ratio 7.10 ± 2.19
Composite diastolic score −0.028 ± 2.11
Values are mean ± SD or number of subjects (%). LA, LV and TDI indicate left atrium
differences: *P ≤ 0.05 vs Belgium; †P ≤ 0.05 vs Poland; ‡P ≤ 0.05 vs Italy.[20] in the QTDT software (version 2.6.1; http://www.sph.
umich.edu/csg/abecasis/QTDT). In this model the
between-family component is sensitive to population
structure whereas the within-family component is signifi-
cant in the presence of transmission disequilibrium.
Results
Characteristics of participants by center, ATP12A alleles
and genotypes and haplotypes frequencies
Table 1 summarizes baseline characteristics of participants
by examination center. Overall, the 1166 white European
participants included 626 (53.7%) women and 522 (44.8%)
hypertensive patients of whom 315 (27.0%) were on anti-
hypertensive drug treatment. Mean age (±SD) was 49.5 ±Poland Italy Russia
(n = 143) (n = 109) (n = 137)
78 (54.6) 60 (55.1) 89 (65.9)*
42.9 ± 13.8* 50.3 ± 13.5† 47.7 ± 14.5*†
169.5 ± 9.1 167.0 ± 9.0† 167.1 ± 9.6†
78.1 ± 15.1 75.2 ± 14.2 77.3 ± 16.2
27.2 ± 5.3 26.9 ± 4.6 27.7 ± 5.6*
137.7 ± 18.9* 125.4 ± 17.1*† 132.4 ± 23.8‡
84.2 ± 11.7* 82.3 ± 10.1* 84.4 ± 14.1*
66.4 ± 11.2* 65.9 ± 10.4* 66.2 ± 10.3*
31 (21.7) 18 (16.5) 35 (25.6)
17 (11.9)* 53 (48.6)† 38 (27.7)†‡
81 (56.6)* 51 (46.8) 67 (48.9)
44 (32.8) 25 (22.9) 49 (35.8)*‡
5.06 ± 0.47 4.91 ± 0.44*† 4.99 ± 0.41
0.96 ± 0.15 0.94 ± 0.15* 0.98 ± 0.18
0.90 ± 0.13 0.88 ± 0.13 0.90 ± 0.13
90.8 ± 20.9 86.0 ± 18.6* 91.2 ± 21.9
63.9 ± 6.56 62.6 ± 6.15 64.1 ± 6.13
74.5 ± 14.9 68.8 ± 14.9*† 67.0 ± 14.5*†
58.6 ± 14.7* 59.6 ± 19.5* 61.0 ± 18.0*
1.36 ± 0.44* 1.28 ± 0.49 1.21 ± 0.49†
11.3 ± 3.51 10.3 ± 3.15*† 10.4 ± 3.40*
9.08 ± 1.93* 10.2 ± 2.12† 9.33 ± 2.05*‡
1.36 ± 0.64 1.07 ± 0.52*† 1.29 ± 0.68‡
7.10 ± 2.16 7.15 ± 2.26 7.04 ± 2.63
0.41 ± 1.93* −0.27 ± 1.92† −0.081 ± 2.07†
, left ventricle and Tissue Doppler Imaging. Significance for between-country
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systolic blood pressure and less frequently reported a daily
alcohol consumption of ≥5 gram than participants from
other centers (Table 1). Composite diastolic Doppler score
were highest in the Polish center compared to the
remaining centers (Table 1). Additional file 1: Table S2
presents baseline characteristics of participants by sex.
Additional file 1: Table S1 lists the chromosome pos-
ition, location type, allele frequencies, call frequencies
and tagged SNPs of the 8 selected ATP12A SNPs. In our
analyses we focused on rs10507337 because it is located
within a transcription factor binding site and, therefore,
it might influence the ATP12A gene expression. The r2
reflecting linkage disequilibrium between rs10507337
and rs12872010 was 0.83. On the other hand, we observed
no correlation between rs10507337 and three other
ATP12A SNPs, rs963984, rs9553395 and rs2071490, with
the r2 values ranged from 0.008 to 0.245, respectively. The
genotype frequencies of rs10507337 complied with Hardy-
Weinberg equilibrium (P = 0.97). Center specific and cu-
mulative rs10507337 genotype distributions are listed in
Table 2. As there were only 5 (0.4%) rs10507337 C allele
homozygotes (all from the Belgian center), we contrasted
rs10507337 C allele carriers with TT homozygotes and,
therefore, use a recessive association model. Additional file
1: Table S3 lists the clinical and echocardiographic charac-
teristics of the participants by rs10507337 genotypes. In
unadjusted analysis, rs10507337 C allele carriers had lower
heart rate, higher transmitral E, E/A ratio, TDI e’ and e’/a’
ratio compared to TT homozygotes. There were no other
differences in clinical or echocardiographic parameters be-
tween these two groups.
We used the selected 5 tag SNPs of ATP12A (rs9553-
395, rs10507337, rs2071490, rs12872010 and rs963984;
Additional file 1: Table S1) to reconstruct haplotypes.
Haplotype frequencies for TTTCC, TTCCA, TTCCC,
CTTCC, CTCCA, CCTTC were 67.4%, 7.1%, 8.5%, 6.9%,
2.3% and 5.3%, respectively.
Composite diastolic score
Because of the high intra-correlation of Doppler diastolic
velocities, we summarized these traits into a single dia-
stolic score using principal component analysis. The first
principal component accounted for 61.5% of the overallTable 2 rs10507337 genotype distribution by country
Country
Genotype
TT N (%) TC N (%) CC N (%)
Belgium (n = 777) 663 (85.3) 109 (14.0) 5 (0.64)
Italy (n = 109) 101 (92.7) 8 (7.34) /
Poland (n = 143) 123 (86.0) 20 (14.0) /
Russia (n = 137) 130 (94.9) 7 (5.11) /
All participants (n = 1166) 1017 (87.2) 144 (12.4) 5 (0.43)variance in the 7 contributing Doppler indexes. Therefore,
we used the first principal component as a normally dis-
tributed summary score (mean 0; standard deviation 1;
Additional file 1: Figure S2). Figure 1 shows factor load-
ings for each of the diastolic Doppler measures which we
used to calculate the composite diastolic score. Partici-
pants with better diastolic function profile (higher trans-
mitral and tissue Doppler velocities during early diastole
and lower E/e’) had higher values of the composite score.
In stepwise multiple regression, the composite diastolic
score significantly and independently decreased with age,
body mass index, heart rate, diastolic blood pressure and
left ventricular mass index (Table 3). The explained vari-
ance totaled 79.2%.
Population-based association study
We adjusted the model for important covariables such
as sex, age, body mass index, heart rate and diastolic
blood pressure as well as for non-independence of ob-
servations within families and centers. Table 4 lists the
adjusted Doppler diastolic indexes and composite score
by rs10507337 genotype by country and in all centers
combined. When all centers were pooled (Table 4), sub-
jects carrying at least one rs10507337 C allele had sig-
nificantly higher values of TDI e’ (P = 5.8×10−5),
transmitral E/A (P = 0.003), TDI e’/a’ (P = 0.003) and
composite diastolic score (P = 0.0001). The heterogeneity
tests (P = 0.04) suggested that there was borderline but
significant heterogeneity among the centers for peaks E
and e’, e’/a’ ratio and composite diastolic score (Table 4).Figure 1 Loading of composite diastolic Doppler score.
Absolute values of bivariate correlations (factor loadings) between the
composite diastolic score and each of the diastolic parameters. The
correlations of transmitral A, TDI a’ and E/e’ ratio to the composite
score were negative and are represented by non-filled points.
Table 3 Correlates of the composite diastolic Doppler score selected in stepwise regression
Parameter Diastolic Doppler score
Partial R2 (%) Parameter estimate ± SE 95%CI P-value
Age (+10 years) 66.0 −1.01 ± 0.021 −1.06 to −0.98 <0.0001
Body mass index (+1 kg/m2) 4.37 −0.080 ± 0.0068 −0.093 to −0.066 <0.0001
Heart rate (+10 beats/minute) 7.49 −0.47 ± 0.029 −0.52 to −0.40 <0.0001
Diastolic pressure (+10 mmHg) 1.08 −0.21 ± 0.029 −0.26 to −0.15 <0.0001
LVMI (+10 g/m2) 0.18 −0.048 ± 0.015 −0.077 to −0.018 0.0016
Total R2 (%) 79.2
Values are mutually adjusted partial regression coefficients ± SE. CI, confidence interval; LVMI, left ventricle mass index.
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pants, who were younger than the participants from
other centers, we did not observe a heterogeneity among
the remaining centers (P > 0.40). Haplotype analysis fur-
ther confirmed that in all subjects combined, composite
diastolic score (P = 0.001; Table 5) and related Doppler
parameters such as TDI e’, E/A, e’/a’ (P ≤ 0.009; Table 6)
were significantly higher in CCTTC carriers than in
noncarriers. This is the only haplotype that included
rs10507337 C allele.Table 4 Adjusted Doppler diastolic indexes and composite sc
Country Genotype LV diastolic indexes adjusted means ±
E peak (cm/s) A peak (cm/s) E/A ratio
Belgium (n = 777) TT (n = 663) 75.2 ± 0.58 65.3 ± 0.51 1.25 ± 0.0
C allele carriers
(n = 114)
76.9 ± 1.32 62.9 ± 1.12 1.34 ± 0.0
P 0.22 0.044 0.0008
Italy (n = 109) TT (n = 101) 67.7 ± 1.68 59.3 ± 1.32 1.27 ± 0.0
C allele carriers
(n = 8)
81.2 ± 4.80 59.1 ± 4.74 1.38 ± 0.1
P 0.006 0.97 0.34
Poland (n = 143) TT (n = 123) 74.4 ± 1.30 58.4 ± 1.06 1.36 ± 0.0
C allele carriers
(n = 20)
72.0 ± 3.31 58.0 ± 2.60 1.34 ± 0.0
P 0.50 0.87 0.80
Russia (n = 137) TT
(n = 130)
65.6 ± 1.24 59.8 ± 1.03 1.20 ± 0.0
C allele carriers
(n = 7)
61.8 ± 4.86 59.1 ± 3.92 1.22 ± 0.1
P 0.45 0.86 0.84
All participants
(n = 1166)
TT (n = 1017) 70.9 ± 1.74 60.8 ± 1.50 1.27 ± 0.0
C allele carriers
(n = 149)
72.9 ± 2.06 59.4 ± 1.76 1.34 ± 0.0
P 0.11 0.19 0.003
P* / / 0.014
P for heterogeneity 0.04 0.81 0.48
Values are least square means ± SE adjusted for family clusters, country (in combine
TDI indicates Tissue Doppler Imaging, SE, standard error. P-values are for the differe
for the differences after Bonferroni adjustment for multiple comparisons.Our findings remained consistent after exclusion of
subjects with history of coronary heart disease or valve
abnormalities (n = 67; Additional file 1: Table S4) or sub-
jects on antihypertensive drugs (n = 315; Additional file 1:
Table S5). For other LV phenotypes (Additional file 1:
Table S6), none of the phenotype-genotype associations
reached statistical significance. With adjustment for
multiple testing applied, we observed that TDI e’, e’/a’
ratio and composite diastolic score were significantly
(P ≤ 0.008) higher in carriers of rs12872010 T alleleore by rs10507337 by country and all centers combined
SE
TDI e’ (cm/s) TDI a’ (cm/s) e’/a’ ratio E/e’ ratio Composite
diastolic score
13 11.3 ± 0.092 10.2 ± 0.084 1.23 ± 0.018 7.13 ± 0.064 −0.097 ± 0.046
28 12.2 ± 0.19 9.99 ± 0.16 1.38 ± 0.038 6.87 ± 0.16 0.35 ± 0.094
8.2×10−6 0.15 0.0002 0.12 3.5×10−6
30 10.3 ± 0.19 10.2 ± 0.17 1.05 ± 0.035 7.11 ± 0.20 −0.30 ± 0.10
1 11.6 ± 0.62 9.87 ± 0.58 1.18 ± 0.11 7.30 ± 0.66 0.26 ± 0.34
0.042 0.58 0.26 0.78 0.12
25 11.4 ± 0.20 9.13 ± 0.15 1.37 ± 0.030 7.05 ± 0.18 0.43 ± 0.087
66 10.8 ± 0.51 9.11 ± 0.38 1.24 ± 0.080 7.16 ± 0.43 0.17 ± 0.22
0.27 0.95 0.14 0.80 0.27
3 10.3 ± 0.19 9.45 ± 0.15 1.24 ± 0.044 6.96 ± 0.20 −0.14 ± 0.11
2 10.4 ± 0.69 9.74 ± 0.57 1.32 ± 0.16 6.20 ± 0.78 0.012 ± 0.38
0.93 0.61 0.62 0.34 0.70
16 10.68 ± 0.25 9.66 ± 0.24 1.22 ± 0.028 7.15 ± 0.11 −0.050 ± 0.036
28 11.36 ± 0.29 9.52 ± 0.27 1.33 ± 0.042 6.98 ± 0.18 0.28 ± 0.083
5.8×10−5 0.32 0.003 0.28 0.0001
0.0007 / 0.007 / 0.0008
0.04 0.79 0.04 0.66 0.04
d analysis), sex, age, body mass index, diastolic blood pressure and heart rate.
nces between rs10507337 TT homozygotes and C allele carriers. P*-values are
Table 5 Composite diastolic Doppler score by ATP12A haplotypes in all centers combined
Number of coded haplotypes
Haplotype 00 01 11 P P*
TTTCC
N (%) 104 (9.0) 552 (47.3) 510 (43.7)
Adjusted 0.19 ± 0.10 −0.012 ± 0.045 −0.057 ± 0.048 0.07 /
TTCCA
N (%) 1005 (86.2) 157 (13.5) 4 (0.34)
Adjusted −0.020 ± 0.037 0.042 ± 0.078 0.45 /
TTCCC
N (%) 972 (83.4) 184 (15.8) 10 (0.86)
Adjusted 0.005 ± 0.037 −0.080 ± 0.072 0.27 /
CTTCC
N (%) 1009 (86.5) 154 (13.2) 3 (0.26)
Adjusted −0.019 ± 0.038 0.041 ± 0.079 0.47 /
CTCCA
No. (%) 1113 (95.5) 53 (4.55) /
Adjusted −0.005 ± 0.035 −0.12 ± 0.13 0.41 /
CCTTC
No. (%) 1047 (89.8) 115 (9.86) 4 (0.34)
Adjusted −0.039 ± 0.036 0.27 ± 0.092 0.001 0.003
Values are least square means ± SE adjusted for family clusters, country, sex, age, body mass index, diastolic blood pressure and heart rate. P*-values are for the
differences after Bonferroni adjustment for multiple comparisons.
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These associations were somewhat expected given
the high correlation between ATP12A rs10507337 and
rs12872010. We did not observe any significant associa-
tions with other tested SNPs (Additional file 1: Tables S8,
S9 and S10) or haplotypes (Table 5).
Family-based association study
Our study population (n = 1166) included 749 founders
and 417 offspring from 357 families. In our family-basedTable 6 Adjusted Doppler diastolic indexes and composite
score by CCTTC haplotype in all centers combined
CCTTC P
LV diastolic indexes 00 (n = 1047) 01 or 11 (n = 119)
Transmitral E peak (cm/s) 71.0 ± 1.75 72.3 ± 2.15 0.33
Transmitral A peak (cm/s) 60.7 ± 1.50 59.5 ± 1.83 0.26
Transmitral E/A ratio 1.27 ± 0.016 1.34 ± 0.031 0.009
TDI e’ peak (cm/s) 10.7 ± 0.25 11.3 ± 0.30 0.0006
TDI a’ peak (cm/s) 9.65 ± 0.24 9.53 ± 0.28 0.42
e’/a’ ratio 1.23 ± 0.028 1.33 ± 0.045 0.008
E/e’ ratio 7.15 ± 0.11 6.97 ± 0.19 0.29
Composite diastolic score −0.039 ± 0.036 0.27 ± 0.092 0.001
Values are least square means ± SE adjusted for family clusters, country, sex,
age, body mass index, diastolic blood pressure and heart rate. P-values are for
the differences between CCTTC carriers and the rest of ATP12A genotypes.analyses we used 74 informative offspring belonging to 35
families (mean age 34.6 ± 8.2 years; 56.9% women). The
number of offspring per informative family amounted to
one in 10 families, two in 17 families, three in 4 families,
and more than three in 4 families. We adjusted the QTDT
analyses as described in the previous section. For LV
diastolic function indexes in relation to rs10507337 ge-
notypes, the orthogonal model did not demonstrate
population stratification (P ≥ 0.08). Transmitral E/A,
TDI e’, TDI e’/a’ and composite diastolic score signifi-
cantly increased with transmission of at least one C
allele to offspring (Table 7). The effect sizes of the within-
family components averaged 0.17 (χ2 = 6.61, P = 0.010) for
E/A, 1.19 cm/s (χ2 = 8.61, P = 0.003) for e’, 0.26 (χ2 = 9.13,
P = 0.003) for e’/a’ and 0.62 (χ2 = 9.04, P = 0.003) for com-
posite score (Table 7).
Discussion
The main finding of the present study was that LV dia-
stolic function as assessed by conventional and tissue
Doppler indexes was associated with genetic variation in
the ATP12A promoter. Carriers of rs10507337 C allele
had better pattern of myocardial relaxation as compared
to non-carriers. Because rs10507337 C allele occurred
only in one reconstructed haplotype (CCTTC), we found
also the significant associations between this haplotype and
LV diastolic function indexes. The family-based analyses
Table 7 Results of the QTDT analyses for the rs10507337
C allele in relation to Doppler diastolic indexes and
composite score
Parameter estimate χ2 P
LV diastolic indexes
Transmitral E peak (cm/s) 1.40 0.22 0.64
Transmitral A peak (cm/s) −3.30 1.59 0.21
Transmitral E/A ratio 0.17 6.61 0.010
TDI e’ peak (cm/s) 1.19 8.61 0.003
TDI a’ peak (cm/s) −0.25 0.21 0.65
TDI e’/a’ ratio 0.26 9.13 0.003
E/e’ ratio −0.33 0.74 0.39
Composite diastolic score 0.62 9.04 0.003
The orthogonal model accounted for between- and within-family variability
components. The parameter estimate for the within-family component of the
rs10507337 C allele indicates the direction and size of the association. Analyses
were adjusted for center, sex, age, body mass index, heart rate and diastolic
blood pressure. TDI, Tissue Doppler Imaging.
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confirmed that transmission of at least one C allele to
offspring was associated with higher transmitral and tis-
sue Doppler velocities during early diastole and com-
posite diastolic score. On the contrary, we did not observe
any association of the genetic variants in ATP12A and
other LV phenotypes including LV mass index and ejection
fraction.
The gold standard for assessing diastolic function re-
mains the pressure-volume relationship, but this requires
an invasive approach. Doppler measurements of mitral in-
flow and the TDI technique open up the possibility of
evaluating non-invasively diastolic function [6]. In our
study, we assessed LV diastolic function non-invasively
using the transmitral flow and the TDI mitral annular vel-
ocities. Previous studies validated these indexes versus
invasive measures of diastolic function [6]. LV diastolic
dysfunction is defined as functional abnormalities that
exist during LV relaxation and filling. Impaired myocardial
relaxation is characterized by decreased early (E peak), but
enhanced atrial LV filling (A peak) as well as less vigorous
mitral annulus motion during early diastole (TDI e’ peak).
Moreover, e’ peak velocity along the LV longitudinal axis is
less susceptible to the effects of an increased preload and
therefore provides a more direct measure of myocardial re-
laxation than, for instance, the transmitral E peak vel-
ocity. In addition, combining transmitral flow velocity
with annular velocity (E/e’ ratio) might be a tool for
assessing the LV filling pressure, which combines the
influence of the transmitral driving pressure and myo-
cardial relaxation [6].
To our knowledge, no previous study reported the associ-
ation of cardiovascular phenotypes with the ATP12A gene.
So far, only a whole DNA array survey in spontaneouslyhypertensive rats identified the ATP12A gene among
probable candidate genes for hypertension [21]. Kinoshita
et al. [21] demonstrated that lower ATP12A expression
might contribute to development of hypertension in
spontaneously hypertensive rats. There is a high level
of structural similarity (up to 86%) in the ATP12A
gene between humans and rodents [16]. The ATP12A
gene product is a catalytic alpha (ATP12Aα) subunit of
an ATP dependent transmembrane electrolyte pump
family (X+-K+-ATPases) [16,19] which is expressed in
human myocardium (http://www.genecards.org/cgi-bin/
carddisp.pl?gene=ATP12A). Functional X+-K+-ATPases
are heterodimers, composed of alpha and beta subunits.
Alpha subunits of ATPases have catalytic and ion-
binding properties [22]. Previous studies in Xenopus
oocytes and human HEK293 cells demonstrated that
ATP12Aα could be assembled to ATPase that functions
as a Na+-K+-pump [17,23]. Moreover, ATP12Aα is sen-
sitive to cardiac glycoside ouabain, specific inhibitor of
Na+-K+-ATPases [24].
Small perturbations in Na+ concentration due to changes
of Na+-K+-ATPase expression and activity, might lead to
important changes of Ca2+ extrusion, a process central for
myocardial contractility and relaxation [11,12]. Schwinger
et al. [25,26] demonstrated that failing human myocardium
had low level of Na+-K+-ATPase concentration and, a con-
sequence, had elevated intracellular Na+ levels [12,13].
Moreover, studies in rodent hearts showed that decrease in
ATP production effects Na+-K+-ATPase activity and leads
to elevated intracellular Na+ concentration [27].
Involvement of Na+-K+-ATPase in electrolyte homeosta-
sis makes ATP12A a possible candidate gene that might
modify cardiac function. In our study, we investigated the
genetic variation which is located in a transcription factor
binding site of the ATP12A promoter area. Several tran-
scription factors can bind this promoter region including
CTCF (CCCTC-binding factor) and NF-kB that both act
in NF-kB cascade [19]. Of notice, levels of NF-kB were in-
creased in failing human myocardium [28]. Therefore, in
conditions related to disturbances in ATP production such
as ischemia or heart failure, these transcription factors
might modify expression of Na+-K+-ATPase.
In our study we observed that subjects with minor C
allele in the ATP12A promoter area had significantly
higher transmitral and tissue Doppler velocities during
early diastole and, therefore, demonstrated an enhanced
early myocardial relaxation compared to overall popula-
tion mean. Overall, these findings might be indicative of
the functional importance of the described genetic vari-
ation in ATP12A. However, we do not know whether
rs10507337 C allele is associated with increased or de-
creased expression of the ATP12A gene. The precise
mechanisms underlying the association of LV diastolic
function with ATP12A remain to be elucidated.
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included measurement of diastolic blood flow (A, E) and
mitral annular movement (a’, e’), and calculation of several
ratios (E/A, e’/a’, E/e’). Since each of these Doppler in-
dexes represents a somewhat distinct feature of diastolic
function, none of them is sufficient to stand alone [1]. On
the other hand, because diastolic Doppler indexes are
measuring the same construct, e.g. velocities of transmitral
blood flow and LV mitral annulus movement during dia-
stole and its ratios, it is possible to reduce the measured
phenotypes into a principal component (composite score)
that will account for most of the variance in the variables.
Indeed, all used diastolic indexes are intra-correlated and,
therefore, some redundancy is expected. This continu-
ously and normally distributed diastolic Doppler score
accounted for 61.5% of the variance in the contributing in-
dexes. In our study, subjects with better diastolic function
had higher values of the composite score. Similarly, the
composite diastolic score was significantly higher in
rs10507337 C allele carriers and in CCTTC haplotype car-
riers. Because of the linkage disequilibrium between
rs10507337 and rs12872010, this association was also ob-
served in rs12872010 minor allele carriers. Hence, our
findings remained consistent and we may conclude that
the composite score of diastolic Doppler velocities might
be used in genomic studies as a phenotype describing LV
diastolic function.
The present study must be interpreted within the con-
text of its limitations and strengths. All participants were
white Europeans. Thus, the association cannot be gener-
alized to other ethnic or racial groups. Transmitral and
TDI diastolic velocities are quantitative echocardio-
graphic traits that arise from complex interaction be-
tween multiple genes, hemodynamic, and environmental
factors and are prone to measurement error. For the
present study, one experienced observer in each center
performed all echocardiographic examinations. Digitally
stored images were post-processed centrally by one ob-
server with high reproducibility [4]. There was also a
high degree of internal consistency between the results
of the population-based and family-based analyses. The
between-family components for rs10507337 were not
statistically significant, which makes it unlikely that our
results are driven by population stratification.
Conclusion
Left ventricular diastolic function as assessed by con-
ventional and tissue Doppler indexes was associated
with genetic variation in the ATP12A promoter. We ob-
served that carriers of rs10507337 C allele or CCTTC
haplotype had better pattern of myocardial relaxation
as compared to non-carriers. Further studies are neces-
sary to clarify the functional significance of this genetic
variation.Additional file
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